[go: up one dir, main page]

BR102015017380A2 - dispositivo para a reticulação do tecido do olho, e, composição farmacêutica - Google Patents

dispositivo para a reticulação do tecido do olho, e, composição farmacêutica

Info

Publication number
BR102015017380A2
BR102015017380A2 BR102015017380A BR102015017380A BR102015017380A2 BR 102015017380 A2 BR102015017380 A2 BR 102015017380A2 BR 102015017380 A BR102015017380 A BR 102015017380A BR 102015017380 A BR102015017380 A BR 102015017380A BR 102015017380 A2 BR102015017380 A2 BR 102015017380A2
Authority
BR
Brazil
Prior art keywords
linking
eye tissue
pharmaceutical composition
tissue cross
cross
Prior art date
Application number
BR102015017380A
Other languages
English (en)
Inventor
Katrin Skerl
Original Assignee
Wavelight Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wavelight Gmbh filed Critical Wavelight Gmbh
Publication of BR102015017380A2 publication Critical patent/BR102015017380A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00853—Laser thermal keratoplasty or radial keratotomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00861—Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00872—Cornea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/008—Methods or devices for eye surgery using laser
    • A61F2009/00878—Planning
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0626—Monitoring, verifying, controlling systems and methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661—Radiation therapy using light characterised by the wavelength of light used ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)

Abstract

dispositivo para a reticulação do tecido do olho, e, composição farmacêutica. a presente divulgação se refere à reticulação do tecido do olho. modalidades de divulgação se referem à ativação de um fotossensibilizador e/ou nanopartículas para reticulação do tecido do olho.
BR102015017380A 2014-08-26 2015-07-21 dispositivo para a reticulação do tecido do olho, e, composição farmacêutica BR102015017380A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102014012675.7A DE102014012675A1 (de) 2014-08-26 2014-08-26 Vernetzung von Augengewebe

Publications (1)

Publication Number Publication Date
BR102015017380A2 true BR102015017380A2 (pt) 2016-04-19

Family

ID=53773174

Family Applications (1)

Application Number Title Priority Date Filing Date
BR102015017380A BR102015017380A2 (pt) 2014-08-26 2015-07-21 dispositivo para a reticulação do tecido do olho, e, composição farmacêutica

Country Status (13)

Country Link
US (1) US9907977B2 (pt)
EP (1) EP2990016B1 (pt)
JP (1) JP6697233B2 (pt)
KR (1) KR20160024770A (pt)
CN (1) CN105380745B (pt)
AU (2) AU2015202642A1 (pt)
BR (1) BR102015017380A2 (pt)
CA (1) CA2891783C (pt)
DE (1) DE102014012675A1 (pt)
ES (1) ES2724334T3 (pt)
MX (1) MX356648B (pt)
RU (1) RU2703703C2 (pt)
TR (1) TR201906047T4 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
EP4420725A3 (en) 2012-03-29 2025-04-16 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
EP3324973B1 (en) 2015-07-21 2020-06-03 Avedro, Inc. Treament of an eye with a photosensitizer
EP3319538A4 (en) 2015-10-23 2018-10-03 The Trustees of Columbia University in the City of New York Laser induced collagen crosslinking in tissue
AU2016396661B2 (en) 2016-03-08 2023-01-19 University Of Utah Research Foundation Cross-linking agents and associated methods
EP3442481B1 (en) 2016-04-13 2023-06-28 Avedro, Inc. Systems for delivering drugs to an eye
WO2017214604A1 (en) 2016-06-10 2017-12-14 The Trustees Of Columbia University In The City Of New York Devices, methods, and systems for detection of collagen tissue features
CN106236372A (zh) * 2016-08-17 2016-12-21 浙江大学 一种数字化角膜交联调节角膜曲率半径的方法及设备
RU2646452C1 (ru) * 2016-11-07 2018-03-05 Государственное бюджетное учреждение "Уфимский научно-исследовательский институт глазных болезней Академии наук Республики Башкортостан" Офтальмологическое средство для ультрафиолетового кросслинкинга роговицы
RU173903U1 (ru) * 2017-02-07 2017-09-18 Государственное бюджетное учреждение "Уфимский научно-исследовательский институт глазных болезней Академии наук Республики Башкортостан" Излучатель устройства для перекрестного сшивания коллагена склеры
RU2645931C1 (ru) * 2017-06-29 2018-02-28 Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации Способ лечения кератэктазий
JP7630988B2 (ja) * 2017-08-18 2025-02-18 ザ ジェネラル ホスピタル コーポレイション ブリルアン分光分析用及び組織のイメージング用のシステム及び方法
US11666481B1 (en) 2017-12-01 2023-06-06 The Trustees Of Columbia University In The City Of New York Diagnosis and treatment of collagen-containing tissues
CN112074252A (zh) * 2018-03-02 2020-12-11 雷萨公司 用于解决、减轻和逆转老花眼的激光方法和系统
CN108403292B (zh) * 2018-03-29 2020-06-19 牟国营 一种巩膜交联设备及使用方法
WO2020219931A1 (en) * 2019-04-26 2020-10-29 The Regents Of The University Of California Nonlinear optical device for micro-machining of the corneal epithelium

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
US7073510B2 (en) * 2000-02-11 2006-07-11 The General Hospital Corporation Photochemical tissue bonding
US9155652B2 (en) * 2001-11-07 2015-10-13 Gholam A. Peyman Method for laser correction of refractive errors of an eye with a thin cornea
US9681942B2 (en) * 2001-11-07 2017-06-20 Gholam A. Peyman Method for prevention of rejection and sever encapsulation of a supportive or functioning implant
JP2005538033A (ja) * 2001-12-04 2005-12-15 ナノスペクトラ バイオサイエンセズ，インク． 過剰なあるいは不適切な新脈管形成によって特徴付けられる病状の治療
EP1819277A4 (en) * 2004-11-12 2010-05-05 Ltd Kpe NANOTE PARTICLE-MEDIATED ULTRASOUND THERAPY AND DIAGNOSTIC IMAGE DISPLAY
WO2008008752A2 (en) * 2006-07-12 2008-01-17 Novartis Ag Actinically crosslinkable copolymers for manufacturing contact lenses
US20100057060A1 (en) * 2007-12-07 2010-03-04 Seros Medical, Llc In Situ UV/Riboflavin Ocular Treatment System
EP2242539B1 (en) * 2008-01-16 2015-04-01 Nanospectra Biosciences, Inc. Nanoparticles for focused hyperthermia to increase efficacy of radiation therapy
JP2012502668A (ja) * 2008-09-19 2012-02-02 アヴェドロ・インコーポレーテッド 眼治療システム
FR2952306B1 (fr) * 2009-11-09 2012-03-30 Creaspine Composition aqueuse utilisee dans le traitement de la reparation de tissu conjonctif fibreux par laser
WO2011084863A2 (en) * 2010-01-07 2011-07-14 Cheetah Omni, Llc Fiber lasers and mid-infrared light sources in methods and systems for selective biological tissue processing and spectroscopy
WO2011094758A2 (en) * 2010-02-01 2011-08-04 Montefiore Medical Center Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye
WO2011137449A2 (en) * 2010-04-30 2011-11-03 Seros Medical, Llc Method and apparatus for treatment of ocular tissue using combined modalities
US20110295243A1 (en) 2010-06-01 2011-12-01 Peyman Gholam A Laser-based methods and systems for corneal surgery
ES2469868T3 (es) * 2010-06-24 2014-06-20 Wavelight Gmbh Dispositivo de preparación de un ojo para aplicar un fotosensibilizador
CN103429266A (zh) * 2010-11-26 2013-12-04 约翰内斯堡金山大学 药物递送装置
WO2012135073A2 (en) * 2011-03-25 2012-10-04 Board Of Trustees Of Michigan State University Adaptive laser system for ophthalmic use
US10463541B2 (en) * 2011-03-25 2019-11-05 Lensar, Inc. System and method for correcting astigmatism using multiple paired arcuate laser generated corneal incisions
RU2456971C1 (ru) * 2011-04-19 2012-07-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения прогрессирующего кератоконуса
US20130310728A1 (en) * 2012-05-16 2013-11-21 Theo Seiler Device for dissecting an eye for the introduction of photosensitizer and method of refractive surgery
JP6275707B2 (ja) * 2012-06-20 2018-02-07 フランク・グー 粘膜付着性ナノ粒子送達系
ES2670506T3 (es) * 2013-01-28 2018-05-30 Novartis Ag Aparato para reticulación corneal
US20160151202A1 (en) * 2013-07-19 2016-06-02 The General Hospital Corporation System, method and arrangements for modifying optical and mechanical properties of biological tissues

Also Published As

Publication number Publication date
US20160059032A1 (en) 2016-03-03
CN105380745A (zh) 2016-03-09
RU2015135997A3 (pt) 2019-03-27
ES2724334T3 (es) 2019-09-10
MX356648B (es) 2018-06-06
AU2017201905A1 (en) 2017-04-13
CA2891783C (en) 2021-05-25
CN105380745B (zh) 2020-05-08
TR201906047T4 (tr) 2019-05-21
CA2891783A1 (en) 2016-02-26
KR20160024770A (ko) 2016-03-07
DE102014012675A1 (de) 2016-03-03
MX2015011056A (es) 2016-10-25
EP2990016B1 (en) 2019-03-13
AU2017201905B2 (en) 2018-01-18
RU2703703C2 (ru) 2019-10-21
JP2016043272A (ja) 2016-04-04
RU2015135997A (ru) 2017-03-02
JP6697233B2 (ja) 2020-05-20
US9907977B2 (en) 2018-03-06
AU2015202642A1 (en) 2016-03-17
EP2990016A1 (en) 2016-03-02

Similar Documents

Publication Publication Date Title
BR102015017380A2 (pt) dispositivo para a reticulação do tecido do olho, e, composição farmacêutica
CO2018005525A2 (es) Formulación farmacéutica acuosa del anticuerpo anti-pd-l1 avelumab
AR102657A1 (es) Composición para tratar telas
BR112017009497A2 (pt) polinucleotídeos de aadc para o tratamento da doença de parkinson
BR112017007123A2 (pt) derivados de tetrahidroisoquinolina
AR102658A1 (es) Composición para el tratamiento de telas
ECSP17015977A (es) Terapia de combinacion
BR112016025470A2 (pt) ?hdl terapêutico?
BR112018003184A2 (pt) absorvente feminino com braçadeiras de barreira
BR112016018878A2 (pt) Copolímero, composição de polímero, e, uso de um copolímero
BR112017002662A2 (pt) processo para preparar furfural e/ou derivados de furfural.
BR112017004745A2 (pt) adição a um aplicador médico
BR112017004893A2 (pt) composições e métodos para o tratamento de lesões cutâneas pré-cancerosas
BR112017013286A2 (pt) composto de isoxazolina, e, uso de um composto de isoxazolina.
BR112016028316A2 (pt) composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento
MX392383B (es) Metodos para tratar afecciones oculares.
EP3559120A4 (en) AQUEOUS POLYMER COMPOSITION
CY1122457T1 (el) Μη πτητικες οφθαλμικες συνθεσεις, ειδικες για τη θεραπεια της ξηροφθαλμιας
SMT202200179T1 (it) Composizione acquosa oftalmica.
EP3688092A4 (en) Aqueous polymer composition
BR112016028083A2 (pt) Composição oral farmacêutica de isotretinoina e seu processo de preparação
BR112016017644A2 (pt) conjugados de fator vii
ITUA20162283A1 (it) Tonometro indossabile perfezionato
TR201819920T4 (tr) Kuru göz sendromunun tedavisinde kullanım için oftalmik bileşimler.
BR112016030057A2 (pt) composição de diagnóstico para identificação de líquido aminiótico

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: NOVARTIS AG (CH)

B25A Requested transfer of rights approved

Owner name: ALCON INC. (CH)

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements